In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia
- PMID: 25614132
- PMCID: PMC4427237
- DOI: 10.1016/j.neubiorev.2015.01.007
In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia
Abstract
In vivo measurement of neurotransmitters and modulators is now feasible with advanced proton magnetic resonance spectroscopy ((1)H MRS) techniques. This review provides a basic tutorial of MRS, describes the methods available to measure brain glutamate, glutamine, γ-aminobutyric acid, glutathione, N-acetylaspartylglutamate, glycine, and serine at magnetic field strengths of 3T or higher, and summarizes the neurochemical findings in schizophrenia. Overall, (1)H MRS holds great promise for producing biomarkers that can serve as treatment targets, prediction of disease onset, or illness exacerbation in schizophrenia and other brain diseases.
Keywords: GABA; Glutamate; Glutathione; Magnetic resonance spectroscopy; Schizophrenia.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
References
-
- Aoyama N, Theberge J, Drost DJ, Manchanda R, Northcott S, Neufeld RW, Menon RS, Rajakumar N, Pavlosky WF, Densmore M, Schaefer B, Williamson PC. Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia. Br J Psychiatry. 2011;198:448–456. - PubMed
-
- Bardaweel SK, Alzweiri M, Ishaqat AA. D-serine in neurobiology: CNS neurotransmission and neuromodulation. Can J Neurol Sci. 2014;41:164–176. - PubMed
-
- Behar KL, Ogino T. Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 1993;30:38–44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
